55 related articles for article (PubMed ID: 3458529)
21. HLA and disease association: the case of gastric cancer.
Rigas B
Gastroenterology; 1996 Aug; 111(2):523-6. PubMed ID: 8690220
[No Abstract] [Full Text] [Related]
22. Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer.
Shen YQ; Zhang JQ; Miao FQ; Zhang JM; Jiang Q; Chen H; Shan XN; Xie W
World J Gastroenterol; 2005 Jun; 11(23):3628-31. PubMed ID: 15962390
[TBL] [Abstract][Full Text] [Related]
23. Human leukocyte antigen (HLA)-E and HLA-F expression in gastric cancer.
Ishigami S; Arigami T; Okumura H; Uchikado Y; Kita Y; Kurahara H; Maemura K; Kijima Y; Ishihara Y; Sasaki K; Uenosono Y; Natsugoe S
Anticancer Res; 2015 Apr; 35(4):2279-85. PubMed ID: 25862890
[TBL] [Abstract][Full Text] [Related]
24. HLA-DR antigens in gastric carcinoma.
Jayanthi M; Habibullah CM; Ishaq M
Immunol Lett; 1990 Jul; 24(4):265-6. PubMed ID: 2391134
[TBL] [Abstract][Full Text] [Related]
25. HLA antigens in acute measles encephalitis.
Lebon P; Ponsot G; Gony J; Hors J
Tissue Antigens; 1986 Feb; 27(2):75-7. PubMed ID: 3486499
[TBL] [Abstract][Full Text] [Related]
26. [Clinical effects of PSK on esophageal and gastric cancer patients and usefulness of serum levels of glycoproteins and HLA antigens as prognostic indicators].
Ogoshi K; Mitomi T
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1443-6. PubMed ID: 2586437
[TBL] [Abstract][Full Text] [Related]
27. HLA antigens in hemophiliacs A with or without factor VIII antibodies in a Venezuelan Mestizo population.
Simonney N; De Bosch N; Argueyo A; Garcia E; Layrisse Z
Tissue Antigens; 1985 Apr; 25(4):216-9. PubMed ID: 3925592
[TBL] [Abstract][Full Text] [Related]
28. [HLA phenotype in patients with osteosarcoma].
Shimizu T
Nihon Seikeigeka Gakkai Zasshi; 1989 Apr; 63(4):269-73. PubMed ID: 2738427
[TBL] [Abstract][Full Text] [Related]
29. HLA-DR7 in children with idiopathic nephrotic syndrome. Correlation with atopy.
de Mouzon-Cambon A; Bouissou F; Dutau G; Barthe P; Parra MT; Sevin A; Ohayon E
Tissue Antigens; 1981 May; 17(5):518-24. PubMed ID: 6950537
[TBL] [Abstract][Full Text] [Related]
30. Genetic analysis of subacute (de Quervain's) thyroiditis.
Goto H; Uno H; Tamai H; Kuma K; Hayashi Y; Matsubayashi S; Sasazuki T
Tissue Antigens; 1985 Aug; 26(2):110-3. PubMed ID: 3877350
[TBL] [Abstract][Full Text] [Related]
31. Expression of HLA-class II antigen in gastric carcinomas. Its relationship to histopathological grade, lymphocyte infiltration and five-year survival rate.
Ma XC; Hattori T; Kushima R; Terata N; Kodama M
Acta Oncol; 1994; 33(2):187-90. PubMed ID: 8204274
[TBL] [Abstract][Full Text] [Related]
32. HLA-DR antigen expression in intestinal-type and diffuse-type gastric carcinoma.
Teh M; Lee YS
Cancer; 1992 Mar; 69(5):1104-7. PubMed ID: 1739908
[TBL] [Abstract][Full Text] [Related]
33. Expression of HLA class I and class II in gastric carcinoma in relation to pathologic stage.
Klein B; Klein T; Nyska A; Shapira J; Figer A; Schwartz A; Rakovsky E; Livni E; Lurie H
Tumour Biol; 1991; 12(2):68-74. PubMed ID: 2028181
[TBL] [Abstract][Full Text] [Related]
34. Is gastric cancer heterogeneity the clue to HLA-DR associated susceptibility?
Sory A; Górski A; Misiuna P; Wallner G; Polkowski W
Acta Oncol; 1994; 33(8):976-8. PubMed ID: 7818935
[No Abstract] [Full Text] [Related]
35. Lack of an association between carcinoma of the stomach and the major histocompatibility complex (HLA) in Cape Coloureds.
Martell RW; van Eeden PJ; Madden MV; du Toit ED; Dent DM
Tissue Antigens; 1988 Sep; 32(3):150-4. PubMed ID: 3217931
[TBL] [Abstract][Full Text] [Related]
36. HLA antigens in stomach cancer.
Nomura A; Glober GA; Terasaki PI; Stemmermann GN
Int J Cancer; 1980 Feb; 25(2):195-6. PubMed ID: 7390648
[TBL] [Abstract][Full Text] [Related]
37. [HLA and otosclerosis].
Nibu K; Okuno T; Nomura Y; Matsuki K; Juji T
Nihon Jibiinkoka Gakkai Kaiho; 1990 Apr; 93(4):606-10. PubMed ID: 2376797
[TBL] [Abstract][Full Text] [Related]
38. The HLA-DR antigen frequency in Northern Ireland compared to the frequency in Bristol, Edinburgh and Eire.
Middleton D; Jordan J; Martin J; Spencer S
Tissue Antigens; 1985 Apr; 25(4):220-1. PubMed ID: 3859947
[No Abstract] [Full Text] [Related]
39. [Role of coagulant cancer antigen 1, tissue factor, and HLA-DR in the procoagulant activity of human gastric cancer cell lines].
Adachi T; Inubo H; Nakatani Y; Wakano O; Yasutomi M
Nihon Shokakibyo Gakkai Zasshi; 1997 Jul; 94(7):513. PubMed ID: 9277118
[No Abstract] [Full Text] [Related]
40. Prognosis in gastric cancer; a study of 5-year survivors.
MAIMON SN; PALMER WL; KIRSNER JB
Am J Med; 1948 Aug; 5(2):230-6. PubMed ID: 18871584
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
